PBF Energy Insider Sold Shares Worth $2,202,922, According to a Recent SEC Filing-March 2024-www.financetom.com

PBF Energy Insider Sold Shares Worth $2,202,922, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

PBF Energy Insider Sold Shares Worth $2,202,922, According to a Recent SEC Filing

Mar 18, 2024 6:46 AM

09:22 AM EDT, 03/18/2024 (MT Newswires) -- Thomas L O Connor, Senior Vice President, on March 14, 2024, sold 40,000 shares in PBF Energy ( PBF ) for $2,202,922. Following the Form 4 filing with the SEC, Thomas L O Connor has control over a total of 160,338 shares of the company, with 160,338 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1534504/000095017024032383/xslF345X03/ownership.xml

Price: 57, Change: +0.35, Percent Change: +0.62

Previous page： Sector Update: Consumer Next page： Kyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tag

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer

Mar 20, 2024

08:48 AM EDT, 03/20/2024 (MT Newswires) -- Consumer stocks were steady pre-bell Wednesday as the Consumer Staples Select Sector SPDR Fund (XLP) and Consumer Discretionary Select Sector SPDR Fund (XLY) were recently inactive. Signet Jewelers' ( SIG ) shares were over 9% lower after the company reported fiscal Q4 sales of $2.5 billion, down from $2.67 billion a year earlier....

Kyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tag

Mar 20, 2024

March 20 (Reuters) - Orchard Therapeutics, a unit of Japan's Kyowa Kirin ( KYKOF ), priced its newly approved gene therapy for a rare, life-threatening genetic disease on Wednesday at $4.25 million, making it the most expensive drug in the United States. The therapy was approved on Monday, in a first for children with a rare disorder called metachromatic leukodystrophy...

Exxon Mobil Insider Sold Shares Worth $271,980, According to a Recent SEC Filing

Mar 20, 2024

08:49 AM EDT, 03/20/2024 (MT Newswires) -- Darrin L Talley, Vice President, on March 19, 2024, sold 2,400 shares in Exxon Mobil ( XOM ) for $271,980. Following the Form 4 filing with the SEC, Talley has control over a total of 220,621 shares of the company, with 186,500 shares held directly and 34,121 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/34088/000112760224010621/xslF345X03/form4.xml...

Hindenburg Research reveals short position in data center operator Equinix

Mar 20, 2024

(Reuters) -Hindenburg Research disclosed a short position in Equinix ( EQIX ) on Wednesday, saying the data center operator trades at elevated levels, has overstated a key profitability metric and faces strong competition from large cloud firms, including Amazon.com. Equinix's ( EQIX ) shares fell 6% in premarket trading, while shares of its rival Digital Realty dropped 4%. The short...